Parabilis Medicines to present updated zolucatetide data at ESMO 2026
Parabilis Medicines said it will present updated Phase 1/2 zolucatetide data in an oral Proffered Paper session at ESMO 2026 on Oct. 24.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.